ARROW® ErgoPack™

The complete vascular access insertion system for infection protection

With the reality of mandatory public reporting of central line–associated bloodstream infections (CLABSIs) and value-based purchasing looming, now is the time to choose a vascular access system designed to prevent infections and their associated expenses.

The Arrow ErgoPack System, when combined with the ARROWg+ard Blue PLUS® or Chlorag+ard® antimicrobial catheter technology, provides defense against all 5 sources of bloodstream infection to help your institution attain and sustain the goal of zero CLABSIs.1-7

The Arrow ErgoPack System combines proven tools for central line insertion that are recommended by the Centers for Disease Control and Prevention, Institute for Healthcare Improvement, and Infusion Nurses Society. The Arrow ErgoPack System includes a 21-step checklist for the insertion team to document that they followed the recommendations of each group.

The Arrow ErgoPack System is a human factors research–based vascular access insertion system designed to:

  • Provide defense against known sources of bloodstream infection1-7
  • Help your institution attain and sustain the goal of zero CLABSIs
  • Reduce procedure time8
  • Allow for more efficient insertions8

An ergonomically designed kit

  • Components organized by sequential insertion steps for easy access and procedural efficiency and standardization
  • Easily accessible checklist and instructions available for reference before opening sterile package
  • Improved labeling for quick and accurate on-the-shelf product identification

The ErgoPack System reduces procedure time8

With its ergonomic design and more compact size, the ErgoPack System is easy to store, and its components are easy to identify during a procedure. The ErgoPack System features:

  • Non-overlapping instrument layout for increased accessibility
  • SharpsAway® II locking disposal cup
  • HemoHopper® fluid receptacle

ARROW, ARROWg+ard Blue PLUS, Chlorag+ard, ErgoPack, HemoHopper and SharpsAway are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.

References: 1. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91(suppl 3B):197S-205S. 2. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231-238. 3. O'Grady NP, Alexander M, Burns LA, et al; and the Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections, 2011. Centers for Disease Control and Prevention. Available at: Accessed April 26, 2011. 4. Fey PD, Matthews KI, Peterson DK, Iwen PC, Hinrichs SH, Rupp ME. Inhibitory effect of explanted chlorhexidine-silver sulfadiazine impregnated central venous catheters on Staphylococcus epidermidis. Presented at: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 19, 2000; Toronto, ON, Canada. 5. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004;30:62-67. 6. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter–related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127:257-266. 7. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter–related infections. Ann Intern Med. 2005;143:570-580. 8. Data on file, Teleflex Incorporated.